Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of a sublingual immunotherapy solution for birch pollen–induced allergic rhinoconj…
-
FDA approval · 2012-11-20FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc. The approval updates the d…
-
CLINICAL_TRIALS trial_result · 2012-11-20Clinical Trial Update: Phase I/IIa Clinical Evaluation of AllerT vs Placebo in Subjects Allergic to Birch Pollen [Phase 1, Phase 2]
Phase I/IIa trial evaluating AllerT versus placebo for birch pollen-induced allergic rhinitis has been terminated. No efficacy or safety res…
-
FDA approval · 2012-11-19FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis [Phase 3]
Phase 3 trial assessing adherence to GRAZAX grass pollen immunotherapy in seasonal allergic rhinitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-11-16FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen [Phase 1]
Phase 1 skin prick test evaluating AllerT in birch pollen-allergic individuals with allergic rhinitis has been completed.
-
CLINICAL_TRIALS trial_result · 2012-11-01Clinical Trial Update: Repeat Dose Nasal Allergen Challenge [NA]
Clinical trial update for a repeat-dose nasal allergen challenge study in allergic rhinitis; no results or current status information is ava…
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Nasya in Allergic Rhinitis [Phase 3]
Phase 3 clinical trial of Nasya for allergic rhinitis has completed; the update notes completion but provides no efficacy results in this sn…
-
FDA approval · 2012-10-18FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approves a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-10-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for montelukast sodium from Torrent Pharmaceuticals Limited, enabling the generic product to be mark…
-
FDA approval · 2012-10-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges* [NA]
A completed clinical trial from Creighton University evaluating the effects of an intranasal corticosteroid and montelukast on nasal allerge…
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma [Phase 1]
A Phase 1 safety study in adults with mild allergic rhinitis, with or without mild asthma, evaluating a reference endotoxin; the trial was t…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays [Phase 3]
Phase 3 trial comparing two mometasone nasal sprays to demonstrate therapeutic equivalence in allergic rhinitis.
-
FDA approval · 2012-09-28FDA Approved: CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s cetirizine hydrochloride and pseudoephedrine hydrochloride as an approved generic product…
-
FDA approval · 2012-09-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-09-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS research · 2012-09-26Clinical Trial Update: Cyanobacteria Allergy in Lake Kineret [NA]
This clinical trial update concerns cyanobacteria allergy exposure at Lake Kineret and describes symptoms consistent with allergic rhinitis,…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Mechanisms of Allergen Immunotherapy [NA]
The document summarizes a terminated clinical trial (NCT01523158) conducted at Royal Sussex County Hospital to study mechanisms of allergen …
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber [Phase 4]
Phase 4 randomized, double-blind, placebo-controlled, four-period crossover study evaluating the dose-response of fluticasone propionate in …
-
FDA approval · 2012-09-21FDA Approved: MONTELUKAST SODIUM — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s Montelukast Sodium Original Application under ANDA 202717, granting a generic version of montelukast s…
-
FDA approval · 2012-09-18FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for montelukast sodium from Lannett Company, Inc., indicating approval of a supplemental (generic) f…
-
CLINICAL_TRIALS research · 2012-09-12Clinical Trial Update: Monitoring of Allergic and Asthmatic Symptoms in Patients Taking Dietary Supplements Joalis Bambi Bronchi and Joalis Bambi Analerg [NA]
A clinical trial update describes monitoring allergic and asthmatic symptoms in children taking the dietary supplements Joalis Bambi Bronchi…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Rinitis y Sinusitis según la Gravedad Del Asma
This completed clinical trial evaluated rhinitis and sinusitis across different asthma severity levels.